Amoxi-Tabs C®-250

Amoxi-Tabs C®-250

Broad-spectrum antibiotic with bacterial resistance inhibitor

Canines Felines Tablet Oral

Amoxicillin base 200 mg, clavulanic acid 50 mg; excipients q.s. ad 1 tablet.

For the treatment of periodontal infections caused by susceptible strains (aerobic and anaerobic bacterias). Treatment of skin and soft tissues infections caused by susceptible species of Staphylococcus spp. E. coli, Pasteurella spp. and Streptococcus spp. Treatment of respiratory tract and urinary tract infections, including those caused by susceptible species of E. coli. Osteomyelitis treatment and other bacterial complications susceptible to amoxicillin.

1 tablet/16 kg every 8 - 12 hours for at least 3 days. Administer through oral route.
Box x 10 tablets , Box x 50 tablets ,

SENASA Registry: SENASA Perú: F.83.31.I.0025

Petmedica® is a division of Agrovet Market S.A.
This content is an informational reference and should not be considered as recommendation of use.

You may also be interested

19_98d807ea41c7515796b0934dd0ebe4e8.png
Amoxi-Tabs C®-250
Broad-spectrum antibiotic with bacterial resistance...
Antibiotics
390_d9a3e3222d64142e0649d495f5cb3fcf.png
Biosporine® 3
Triple Topical Broad Spectrum Antibiotic...
Antibiotics
352_c73c4d242d1210b9160d972ca457d79f.png
Cefoxi-Tabs® C
Last Generation Cephalosporin Antibiotic with...
Antibiotics